Bridge Pharmaceuticals Outsources Research to Beijing Facility

Published November 2005

BEIJING, CHINA -

Menlo Park, Calif.-based Bridge Pharmaceuticals is opening a 100,000-sf research facility in the Zhong-guancun Life Science Park in Beijing, China. The facility is designed to meet U.S. regulatory standards for animal testing and laboratory practice. Additionally, the contract research company is planning to acquire a preclinical testing facility in Taiwan.

Copyright 2008 Tradeline Inc.
All Rights Reserved
ISSN: 1096-4894